Hollsteen
← Veeva

Equity incl. NCI

Balance – as of period end · $M

QuartersFiscal years

$MEquity incl. NCI · Q1 FY2016: $429M · 10-Q 0001564590-15-004860 filed Jun 4, 2015Equity incl. NCI · Q2 FY2016: $454M · 10-Q 0001564590-15-007757 filed Sep 4, 2015Equity incl. NCI · Q3 FY2016: $474M · 10-Q 0001564590-15-011387 filed Dec 10, 2015Equity incl. NCI · Q4 FY2016: $522M · 10-K 0001564590-19-009853 filed Mar 28, 2019Equity incl. NCI · Q1 FY2017: $531M · 10-Q 0001564590-16-020379 filed Jun 8, 2016Equity incl. NCI · Q2 FY2017: $565M · 10-Q 0001564590-16-025058 filed Sep 8, 2016Equity incl. NCI · Q3 FY2017: $606M · 10-Q 0001564590-16-030006 filed Dec 8, 2016Equity incl. NCI · Q4 FY2017: $678M · 10-K 0001564590-19-009853 filed Mar 28, 2019Equity incl. NCI · Q1 FY2018: $709M · 10-Q 0001564590-17-012336 filed Jun 8, 2017Equity incl. NCI · Q2 FY2018: $767M · 10-Q 0001564590-17-018414 filed Sep 7, 2017Equity incl. NCI · Q3 FY2018: $818M · 10-Q 0001564590-17-024561 filed Dec 6, 2017Equity incl. NCI · Q4 FY2018: $906M · 10-K 0001564590-19-009853 filed Mar 28, 2019Equity incl. NCI · Q1 FY2019: $974M · 10-Q 0001564590-18-015244 filed Jun 7, 2018Equity incl. NCI · Q2 FY2019: $1.1B · 10-Q 0001564590-18-022767 filed Sep 6, 2018Equity incl. NCI · Q3 FY2019: $1.1B · 10-Q 0001564590-18-030635 filed Dec 7, 2018Equity incl. NCI · Q4 FY2019: $1.2B · 10-K 0001564590-19-009853 filed Mar 28, 2019Equity incl. NCI · Q1 FY2020: $1.3B · 10-Q 0001564590-19-021933 filed Jun 6, 2019Equity incl. NCI · Q2 FY2020: $1.4B · 10-Q 0001628280-19-011445 filed Sep 5, 2019Equity incl. NCI · Q3 FY2020: $1.6B · 10-Q 0001628280-19-014779 filed Dec 5, 2019Equity incl. NCI · Q4 FY2020: $1.7B · 10-K 0001628280-20-004385 filed Mar 30, 2020Equity incl. NCI · Q1 FY2021: $1.8B · 10-Q 0001628280-20-008982 filed Jun 4, 2020Equity incl. NCI · Q2 FY2021: $2.0B · 10-Q 0001628279-20-000207 filed Sep 8, 2020Equity incl. NCI · Q3 FY2021: $2.1B · 10-Q 0001628280-20-017286 filed Dec 9, 2020Equity incl. NCI · Q4 FY2021: $2.3B · 10-K 0001393052-21-000015 filed Mar 30, 2021Equity incl. NCI · Q1 FY2022: $2.4B · 10-Q 0001393052-21-000028 filed Jun 4, 2021Equity incl. NCI · Q2 FY2022: $2.6B · 10-Q 0001393052-21-000034 filed Sep 3, 2021Equity incl. NCI · Q3 FY2022: $2.8B · 10-Q 0001393052-21-000040 filed Dec 3, 2021Equity incl. NCI · Q4 FY2022: $2.9B · 10-K 0001393052-22-000017 filed Mar 30, 2022Equity incl. NCI · Q1 FY2023: $3.1B · 10-Q 0001393052-22-000025 filed Jun 3, 2022Equity incl. NCI · Q2 FY2023: $3.2B · 10-Q 0001393052-22-000036 filed Sep 2, 2022Equity incl. NCI · Q3 FY2023: $3.4B · 10-Q 0001393052-22-000048 filed Dec 7, 2022Equity incl. NCI · Q4 FY2023: $3.7B · 10-K 0001393052-23-000025 filed Mar 30, 2023Equity incl. NCI · Q1 FY2024: $3.9B · 10-Q 0001393052-23-000034 filed Jun 2, 2023Equity incl. NCI · Q2 FY2024: $4.2B · 10-Q 0001393052-23-000051 filed Sep 1, 2023Equity incl. NCI · Q3 FY2024: $4.4B · 10-Q 0001393052-23-000066 filed Dec 7, 2023Equity incl. NCI · Q4 FY2024: $4.6B · 10-K 0001393052-24-000013 filed Mar 25, 2024Equity incl. NCI · Q1 FY2025: $4.9B · 10-Q 0001393052-24-000024 filed Jun 4, 2024Equity incl. NCI · Q2 FY2025: $5.2B · 10-Q 0001393052-24-000062 filed Sep 4, 2024Equity incl. NCI · Q3 FY2025: $5.5B · 10-Q 0001393052-24-000075 filed Dec 9, 2024Equity incl. NCI · Q4 FY2025: $5.8B · 10-K 0001393052-25-000022 filed Mar 24, 2025Equity incl. NCI · Q1 FY2026: $6.2B · 10-Q 0001393052-25-000042 filed Jun 2, 2025Equity incl. NCI · Q2 FY2026: $6.6B · 10-Q 0001393052-25-000067 filed Aug 29, 2025Equity incl. NCI · Q3 FY2026: $7.0B · 10-Q 0001393052-25-000078 filed Nov 21, 2025Equity incl. NCI · Q4 FY2026: $7.2B · 10-K 0001393052-26-000014 filed Mar 20, 2026Equity incl. NCI · Q1 FY2027: $7.3B · 10-Q 0001393052-26-000026 filed Jun 5, 2026Equity incl. NCI · Q2 FY2027: $7.4B · 10-Q 0001393052-26-000036 filed Aug 27, 20261,9577,431429Q1 FY2016Q2 FY2027Q2 FY2021
Q2 FY2021
1,957$M
All values (46)
PeriodValue ($M)Status
Q2 FY20277,431reported
Q1 FY20277,304reported
Q4 FY20267,215reported
Q3 FY20267,041reported
Q2 FY20266,639reported
Q1 FY20266,211reported
Q4 FY20255,832reported
Q3 FY20255,501reported
Q2 FY20255,185reported
Q1 FY20254,889reported
Q4 FY20244,645reported
Q3 FY20244,380reported
Q2 FY20244,153reported
Q1 FY20243,943reported
Q4 FY20233,716reported
Q3 FY20233,419reported
Q2 FY20233,244reported
Q1 FY20233,068reported
Q4 FY20222,912reported
Q3 FY20222,769reported
Q2 FY20222,620reported
Q1 FY20222,445reported
Q4 FY20212,266reported
Q3 FY20212,106reported
Q2 FY20211,957reported
Q1 FY20211,801reported
Q4 FY20201,666reported
Q3 FY20201,559reported
Q2 FY20201,445reported
Q1 FY20201,335reported
Q4 FY20191,238reported
Q3 FY20191,138reported
Q2 FY20191,050reported
Q1 FY2019974reported
Q4 FY2018906reported
Q3 FY2018818reported
Q2 FY2018767reported
Q1 FY2018709reported
Q4 FY2017678reported
Q3 FY2017606reported
Q2 FY2017565reported
Q1 FY2017531reported
Q4 FY2016522reported
Q3 FY2016474reported
Q2 FY2016454reported
Q1 FY2016429reported

CSV with all sources · Technical ID: equity_total

More metrics for Veeva
Sources & calculation
Value
$2.0B
Period
Q2 FY2021, ended Jul 31, 2020 · as of Jul 31, 2020 (balance as of date, not a sum)
Source
10-Q, filed Sep 8, 2020 · 0001628279-20-000207
Location
us-gaap:StockholdersEquity
Confidence
1. – directly from an XBRL fact in the filing (or calculated exactly from it)

Versions

v1$2.0BSep 8, 202010-Q 0001628279-20-000207reported · confidence 1. · current